Urease-powered nanobots have shown remarkable potential in the treatment of bladder cancer, achieving a substantial reduction in tumor size. Bladder Cancer — Current Challenges Bladder cancer is a common and…

The Evolution of Theranostic Agents: A Historical Perspective The development of theranostic agents, which seamlessly integrate diagnostics and therapeutics, has transformed cancer treatment. Initially, these agents relied heavily on conventional…

A bacteria-responsive hydrogel with self-activating antibacterial properties offers a promising solution for accelerating the healing of infected wounds. Background Infected wounds, particularly those associated with chronic bacterial infections, present significant…

Introduction: Decoding Tumor Evasion Strategies Cancer cells have developed sophisticated mechanisms to evade the immune system, allowing them to proliferate unchecked. One prominent strategy is the overexpression of CD47, a…

Background Diabetic osteoporosis (DOP) is a severe complication of diabetes that weakens bones, increasing the risk of fractures and other skeletal issues. Despite its prevalence, effective treatments for DOP remain…

In recent years, MXenes have emerged as a groundbreaking class of two-dimensional (2D) materials, captivating the scientific community with their unique properties and versatile applications. First discovered in 2011, MXenes…

Xi’an, China – A groundbreaking innovation in wound care aims to combat the challenges posed by drug-resistant infections and promote faster healing. Background Wound infections caused by drug-resistant bacteria have…

The Evolution of Nanoparticle-Based Cancer Therapies Historically, cancer therapies have relied on conventional methods such as surgery, radiation, and chemotherapy. However, the advent of nanoparticles has opened new doors in…